Clinical decision-support only. For use by licensed dental professionals. Not a substitute for professional judgment or a complete drug reference. Always verify with primary sources.
← Back to search
Allergy

Sulfonamide (sulfa) allergy

Antibiotic

Drug classes to avoid

Sulfonamide

Reaction signs & chairside management

  • Allergic reaction or severe rash on exposure (sulfonamide hypersensitivity)

    Reactions to sulfonamide antibiotics range from rash to severe cutaneous reactions (e.g. Stevens-Johnson syndrome, rare). Sulfonamide non-antibiotics (e.g. some diuretics) do not reliably cross-react.

    Clinical management: Avoid sulfonamide antibiotics. This rarely affects routine dental prescribing since sulfonamides are not first-line for oral infections.

  • Painful mouth and lip sores with peeling lining (Stevens-Johnson syndrome / toxic epidermal necrolysis)

    A rare but life-threatening delayed drug reaction in which the skin and mucous membranes blister and peel; anti-infective sulfonamides (e.g. sulfamethoxazole-trimethoprim) are the drugs most strongly linked to it; the mouth and lips are involved in most cases, with widespread erosions, crusted bleeding lips and painful swallowing.

    Clinical management: Ask about any past severe rash with mouth sores or blistering, and treat that history as an absolute contraindication to the drug (record it clearly). A patient with new mouth/lip erosions plus fever, rash or eye irritation while on a recent antibiotic needs same-day medical referral. During recovery, keep oral care gentle: soft brush or sponge swabs, bland or chlorhexidine rinses, and lip emollient.

Sources

  1. Sulfonamide Hypersensitivity: Fact and Fiction. Khan DA, Knowles SR, Shear NH. The journal of allergy and clinical immunology. In practice, 2019.
  2. Sulfonamide Hypersensitivity. Chow TG, Khan DA. Clinical reviews in allergy & immunology, 2022.
  3. A Systematic Review of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Epidemiology and Treatment Strategies. Wang B, Zhan J, Liao W et al. International journal of general medicine, 2026.
  4. Summary of the Best Evidence on Skin-Mucosal Care in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Lei Y, Ding Z, Yuan C et al. Advances in skin & wound care, 2025.